Madrigal Pharmaceuticals, Inc. (MDGL)

NMS – Real Time Price. Currency in USD

540.88

+5.61 (1.05%)

Market open: Aug 12, 2026, 11:35 AM EDT

534.99

-0.28 (-0.05%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

06.08.2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

CONSHOHOCKEN, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it granted equity awards on August 1, 2026 to ten new non-executive employees as equity inducement awards under the terms of Madrigal's 2025 Inducement Plan.

06.08.2026

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

CONSHOHOCKEN, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that the company will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, Aug. 11, 2026 at 12:00 P.M. EDT.

Videos

No Data

There is no data to display

Upgrades / Downgrades

Ticker	Brokerage Firm	Ratings Change	Price Target	Date
MDGL	Wolfe Research	Outperform	undefined >> $605	August 4th 2026

Press releases

06.08.2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

06.08.2026

Madrigal Pharmaceuticals, Inc. (MDGL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Search stocks

Madrigal Pharmaceuticals, Inc. (MDGL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Videos

No Data

Upgrades / Downgrades

Press releases

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference